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Importance: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) autoimmune encephalitis is an increasingly
recognized cause of limbic encephalitis (LE). Prolonged LE and limbic status epilepticus (LSE) share many
features. The ability to distinguish between the two is crucial in directing appropriate therapy because of the
potential iatrogenesis associated with immunosuppression and anesthetic-induced coma.
Observations: A 34-year-old womanwith recurrent LE developed behavioral changes, global aphasia, and repetitive
focal and generalized tonic–clonic seizures. Because asymmetric rhythmic delta patterns recurred on electroenceph-
alography (EEG) despite treatment with nonsedating antiepileptic drugs followed by anesthetic-induced coma, an
investigation to distinguish LSE from LEwas undertaken. Implanted limbic/temporal lobe depth electrodes revealed
no epileptiform activity. Brain single-photon emission computerized tomography (SPECT) showed no hyperperfu-
sion, and brain ﬂuorodeoxyglucose-positron emission tomography (FDG-PET) showed hypermetabolism in the
left frontal, temporal, and parietal cortices. Anti-N-methyl-D-aspartate receptor autoimmune encephalitis was
diagnosed based detection of anti-NMDAR antibody in the cerebrospinalﬂuid (CSF).With chronic immunosuppres-
sion, the resolution of brain FDG-PET abnormalities paralleled clinical improvement.
Conclusions and relevance: This case of anti-NMDAR autoimmune encephalitis illustrates the challenges
of distinguishing prolonged LE from LSE. We discuss the parallels between these two conditions and propose a
management paradigm to optimize evaluation and treatment.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Limbic encephalitis (LE) is considered in patients with short-term
memory loss, confusion, behavioral changeswith irritability, depression,
sleep disturbance, hallucinations, orofacial dyskinesias, and seizures
involving the medial temporal lobes and amygdala [1,2]. Encephalitis
with anti-N-methyl-D-aspartate receptor (anti-NMDAR) antibodies is
an autoimmune, and often paraneoplastic, form of LE with prodromal
viral-like illness, prominent impaired consciousness, abnormal move-
ments, and autonomic instability [3]. Prolonged states of behavioral
changes, orofacial movements, and partial seizures in LE suggest
underlying limbic status epilepticus (LSE) [4]. When facing the, The Johns Hopkins University
13, Baltimore, MD 21205, USA.
. This is an open access article underdiagnostic dilemmaof autoimmune LE and LSE, antiepileptic and immu-
nosuppressive treatment is often initiated while awaiting conﬁrmatory
antibody titers. However, patients may develop refractory or malignant
features with diagnostically ambiguous rhythmic activity on electroen-
cephalography (EEG). The clinician must weigh the morbidity of ongo-
ing limbic seizures against the morbidity of anesthetic-induced coma
in an effort to overcome suspected LSE. Here, we present a case where
this conundrum was explored using surface and depth electrode EEG.
We propose a paradigm for distinguishing LE from LSE.
2. Report of a case
A34-year-oldwomanwith a history of two episodes of LE in the prior
nine years developed gradual onset difﬁculty with concentration, mild
headaches, and hemibody paresthesias that progressed to include
orofacial dyskinesias, hemiparesis, global aphasia, and repetitive focal
and generalized tonic–clonic seizures. Her previous episodes of LE, fromthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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changes, aphasia, and focal and generalized tonic–clonic seizures. She
had a family history of autoimmunity, with a mother with Sjögren's dis-
ease and a maternal aunt with systemic lupus erythematosus. Her initial
evaluation revealed a cerebrospinal ﬂuid (CSF) lymphocytic pleocytosis
(46 leukocytes/mm3) and elevated protein (95 mg/dL), with negative
anti-NMDAR serologies. Fluorodeoxyglucose-positron emission tomog-
raphy (FDG-PET) performed during the ﬁrst clinical episode demonstrat-
ed multiple FDG-avid hypermetabolic areas involving the right frontal,
temporal, and parietal lobes. She was treated with high-dose intrave-
nous (IV) corticosteroids, intravenous immunoglobulin (IVIg), and oral
corticosteroid taper. A corticomeningeal biopsy was nondiagnostic.
The brain FDG-PET abnormality resolved prior to the second clinical
episode. She was subsequently treated with a regimen of lamotrigine,
carbamazepine, and oral prednisone.
Five years after her second clinical episode, she experienced trouble
concentrating at work with intermittent headaches and presented to
her neurologist for evaluation. Outpatient brain magnetic resonance
imaging (MRI) revealed a T2 hyperintensity in the left parietal lobe
that prompted hospitalization and CSF analysis showing a lymphocytic
pleocytosis (103 leukocytes/mm3) and normal protein (42 mg/dL). By
report, EEG demonstrated intermittent irregular slowing over the left
temporal region, without epileptiform discharges. Following high-dose
IV corticosteroids, she was discharged on oral corticosteroid taper,
carbamazepine, and lamotrigine. She continued to have language
deﬁcits, right arm weakness, and difﬁculty with feeding and dressingFig. 1. Continuous surface and depth electrode electroencephalographic monitoring in anti-NM
was maximal over the left temporal area. (B) Surgically implanted depth electrodes targe
semirhythmic to rhythmic delta activity that correlated with surface EEG slowing.herself. A follow-up outpatient brain MRI was normal. Within weeks,
she developed episodic right face twitching, right hemibody paresthe-
sias with hemiparesis, and generalized tonic–clonic seizures. She was
readmitted, given IV antiepileptic drugs, and reinitiated on high-dose
IV corticosteroids. Per report, repeat CSF studies and EEG were
unchanged from prior studies, showing lymphocytic pleocytosis
(76 leukocytes/mm3) with normal protein (36 mg/dL) and focal left
temporal slowing. Following prolonged right facial twitching and gen-
eralized abnormal movements, IVIg was initiated, and she was trans-
ferred to our hospital for further evaluation and management.
On admission, she was alert and nonverbal with global aphasia.
Intermittent right facial twitches and right arm movements were
noted. Motor examination showed antigravity strength in the left
hemibody and right leg. No purposeful movements of the right arm
were noted. Electrographic seizures with clinical correlates were
captured on EEG, so her antiepileptic regimen was escalated. On subse-
quent continuous EEG monitoring, intermittent rhythmic left temporal
delta activity was seen (Fig. 1A), without sharps or epileptiform wave-
forms. Repeat CSF analysis showed persistent lymphocytic pleocytosis
(53 leukocytes/mm3), and serologic inﬂammatory and rheumatologic
markers were normal. A brain single-photon emission computerized to-
mography (SPECT) study showed no abnormal perfusion (data not
shown). Clinically, she had ﬂuctuating worsening of her aphasia and
right arm weakness that correlated with temporal delta activity
that would progress and evolve asymmetrically and rhythmically
in bursts of 10 s. Levetiracetam, fosphenytoin, valproic acid, lacosamide,DAR autoimmune encephalitis. (A) Scalp EEGmonitoring demonstrated delta slowing that
ting the left amygdala (AMG) and left hippocampus (HIP) showed nearly continuous
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completed a 2-g/kg course of IVIg and ﬁve days of high-dose IV methyl-
prednisolone and was treated with prednisone 60 mg daily. Based on
concern for LSE, propofol was used to suppress the rhythmic delta activ-
ity, but this recurred with each attempt at propofol weaning and despite
addition of phenobarbital. As discussed elsewhere, the ketogenic diet
was initiated for super-refractory SE [5]. After a total of eightweekswith-
out clinical or EEG remission and despite multiple rounds of anesthetic-
induced electrographic burst suppression, a point of risk/beneﬁt equi-
poise was raised. The iatrogenesis of further anesthetic-induced coma
with immunosuppressant treatment was thought to possibly outweigh
the ambiguity of treating rhythmic delta activity at the scalp surface on
the assumption that this represented LSE at the depths, particularly in
the case of idiopathic LE. Depth electrodemonitoringwas utilized to de-
termine if the rhythmic delta activity was indeed epileptic since rhyth-
mic delta activity can be a scalp ictal pattern for seizures originating
from mesial temporal structures [6].
During 14 days of simultaneous continuous monitoring of scalp EEG
and surgically implanted intracranial depth electrodes targeting the left
amygdala and left hippocampus, no spike or spike–wave activity was
recorded. Rather, both surface and depth electrodes demonstratedFig. 2. Serial brainﬂuorodeoxyglucose-positron emission tomography image analysis in anti-NM
obtained at indicated times from symptomonset. Baseline scan showed increased FDG-avid hyp
these hypermetabolic cortical abnormalities essentially resolved by six months. (B) Statistical im
ysis using NEUROSTAT (provided by theDepartment of Radiology, University ofWashington, Se
control database. All imageswerenormalized to global brain activity (GLB). Baseline FDG-PET im
cortices. Serial FDG-PET imaging at two and sixmonths after symptomonset showed interval re
(consistent with crossed diaschisis) that improved over serial scans.near continuous semirhythmic to rhythmic slow delta activity that
wasmaximal over the left temporal area on scalp EEG (Fig. 1B). Notably,
brain FDG-PET showed asymmetric FDG-avidity in the left frontal,
temporal, and parietal cortices (Figs. 2A and B). In the absence of clear
ictal patterns, this increased metabolic activity was attributed to LE,
and the ketogenic diet and phenobarbital were tapered off. Given
concern for an autoimmune etiology, the patient was treated with ﬁve
exchange courses of plasmapheresis. When the anti-NMDAR antibody
test returned positive from her CSF (not serum), shewas initiated on ri-
tuximab, started on a slow oral prednisone taper, and transitioned to le-
vetiracetam and lamotrigine for seizure prophylaxis. Abdominal and
transvaginal ultrasounds and pelvic MRI were unremarkable. Whole-
body FDG-PET/CT failed to reveal occult malignancy. Her aphasia grad-
ually improved over six months, along with improvements in the met-
abolic asymmetry on brain FDG-PET (Figs. 2A and B).
3. Discussion
We present a patient with recurrent episodes of LE, where no etiol-
ogy had been identiﬁed after multiple hospitalizations over nine years.
The ultimate diagnosis of anti-NMDAR autoimmune encephalitis byDAR autoimmune encephalitis. (A) Representative transaxial and coronal FDG-PET images
ermetabolism in the left temporal and parietal regions.With chronic immunosuppression,
ages were generated by three-dimensional stereotactic surface projection (3D-SSP) anal-
attle,WA,USA). Images represent Z scores above themean comparedwith an age-matched
ages demonstrated asymmetric hypermetabolism in the left temporal, parietal, and frontal
solution of FDG-avid cortical asymmetry. Therewas also right cerebellar hypermetabolism
Fig. 3. Diagnostic and therapeutic approach to patients with suspected autoimmune limbic encephalitis.
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sizes the importance of testing CSF and serumwhen evaluating patients
in whom autoimmune LE is suspected [7]. Notably, her serum remained
negative for anti-NMDAR as well as other autoantibodies.
The EEG is typically abnormal in anti-NMDAR encephalitis [7], with
predominantly low-voltage delta to theta range activity [8–11]. Here,
we demonstrate that the rhythmic delta activity on surface EEG in a
patient with anti-NMDAR autoimmune encephalitis was not associated
with evidence of cyclic spike or spike–wave activity on depth recording.
This important observation addresses the question as to whether
rhythmic slowing on the surface EEG represents LSE or a form of
nonconvulsive status epilepticus in anti-NMDAR encephalitis [4,9].
Brain PET FDG-avid hypermetabolism in mesiotemporal structures
has been reported in autoimmune LE and has been correlated with
focal slow activity on surface EEG in anti-NMDAR encephalitis [12–14].
With serial brain FDG-PET scans,we found asymmetric cortical hyperme-
tabolism in anti-NMDAR encephalitis, and the rhythmic slowing in depth
and surface EEG was attributed to encephalitic changes. Indeed, it was
with escalation of immunotherapy and optimization of prophylactic anti-
epileptic drugs that our patient began to improve clinically. Furthermore,
the resolution of the brain FDG-PET abnormalities paralleled the amelio-
ration of symptoms with chronic suppression immunotherapy.
The lessons learned from this case inform a diagnostic and therapeutic
approach (Fig. 3) that focuses on efﬁcient and deliberate interventions to
reduce potential iatrogenic morbidity and, conversely, to improve appro-
priate management in cases of suspected autoimmune LE, particularly in
anti-NMDAR encephalitis [7,15]. In prolonged anti-NMDAR LE, when
rhythmic delta activity persists despite anesthetic-induced burst suppres-
sion and immunotherapy, the use of depth electrodes has been proposed
to help distinguish LE from LSE [4].We present a patient in whom persis-
tent surface rhythmic delta activity did not correlate with depth spike or
spike–wave activity butwas concurrentwithdepth recording of rhythmic
delta activity. Clinical improvement was realized with the introduction
of second-line immunotherapies, allowing for optimization of theantiepileptic regimen.Weoutline a paradigm thatmay be helpful inman-
aging autoimmune LE and distinguishing features from LSE.
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